117 related articles for article (PubMed ID: 6804671)
1. [High-performance liquid chromatographic determination of urinary 5-S, 2-S-, 6-S-cysteinyldopa and 2,5-S,S-dicysteinyldopa (author's transl)].
Morishima T; Saito M; Fujita M; Fukada E; Hanawa S
Nihon Hifuka Gakkai Zasshi; 1982 Jan; 92(1):53-6. PubMed ID: 6804671
[No Abstract] [Full Text] [Related]
2. [Urinary 5-S-cysteinyldopa in malignant melanoma subjects-with special reference to melanoma stages and dopa loading test (author's transl)].
Ichihasi M; Mojamdar M; Mishima Y
Nihon Hifuka Gakkai Zasshi; 1981 Sep; 91(10):1045-9. PubMed ID: 6798247
[No Abstract] [Full Text] [Related]
3. Cysteinyldopa isomers and dopa in lesions and urine of Japanese patients with malignant melanoma.
Morishima T; Tatsumi F; Fukada E; Saito M; Fujita M; Nagashima N; Hanawa S
Arch Dermatol Res; 1983; 275(2):76-9. PubMed ID: 6409012
[TBL] [Abstract][Full Text] [Related]
4. Isolation of 2-S-cysteinyldopa and 2,5-S,S-dicysteinyldopa from the urine of patients with melanoma.
Prota G; Rorsman H; Rosengren AM; Rosengren E
Experientia; 1977 Jun; 33(6):720-1. PubMed ID: 891724
[No Abstract] [Full Text] [Related]
5. [Therapeutic evaluation of human malignant melanoma by urinary 5-S-cysteinyldopa dynamics: chemotherapy and surgery].
Inoi T; Mojamdar M; Ichihashi M; Mishima Y
Nihon Hifuka Gakkai Zasshi; 1984 Jan; 94(1):39-43. PubMed ID: 6433083
[No Abstract] [Full Text] [Related]
6. Urinary 5-S-cysteinyldopa in Parkinsonism after DOPA and carbidopa.
Stewart RM; Miller S; Gunder M
Acta Derm Venereol; 1983; 63(2):97-101. PubMed ID: 6189350
[TBL] [Abstract][Full Text] [Related]
7. Determination of urinary 5-S-cysteinyldopa by high-performance liquid chromatography.
Kågedal B; Pettersson A
J Chromatogr; 1983 Feb; 272(2):287-97. PubMed ID: 6403561
[TBL] [Abstract][Full Text] [Related]
8. 5-S-cysteinyldopa in the urine of melanoma patients.
Agrup G; Agrup P; Andersson T; Falck B; Hansson JA; Jacobsson S; Rorsman H; Rosengren E; Rosengren AM
Acta Derm Venereol; 1977; 57(2):113-6. PubMed ID: 71802
[TBL] [Abstract][Full Text] [Related]
9. 5 years' experience of 5-S-cysteinyldopa in melanoma diagnosis.
Agrup G; Agrup P; Andersson T; Hafström L; Hansson C; Jacobsson S; Jönsson PE; Rorsman H; Rosengren AM; Rosengren E
Acta Derm Venereol; 1979; 59(5):381-8. PubMed ID: 93360
[TBL] [Abstract][Full Text] [Related]
10. [5-S-cysteinyldopa determination in the urine. Its value for monitoring in melanoma patients].
Paul E; Graef V; Ruppel R; Hellwich M
Z Hautkr; 1983 Feb; 58(4):262-5. PubMed ID: 6405551
[TBL] [Abstract][Full Text] [Related]
11. [Urinary evaluation of 5-S-cysteinyldopa and seric evaluation of IgG4 subclass during follow-up of 27 primitive malignant melanomas (author's transl)].
Cesarini JP; Daveau M; Picard F; Fournier E; Rivat L; Rivat C
Ann Dermatol Venereol; 1978 Apr; 105(4):405-8. PubMed ID: 686614
[TBL] [Abstract][Full Text] [Related]
12. Automated high-performance liquid chromatographic determination of 5-S-cysteinyl-3,4-dihydroxyphenylalanine in urine.
Kågedal B; Källberg M; Arstrand K; Hansson C
J Chromatogr; 1989 Jul; 473(2):359-70. PubMed ID: 2504759
[TBL] [Abstract][Full Text] [Related]
13. [Correlation of urinary 5-S-cysteinyldopa with repeated remission of melanoma induced by DTIC combination chemotherapy].
Inoi T; Mojamdar M; Ichihashi M; Mishima Y
Nihon Hifuka Gakkai Zasshi; 1982 Sep; 92(10):1065-9. PubMed ID: 6821170
[No Abstract] [Full Text] [Related]
14. Urinary free and conjugated 5-S-cysteinyldopa in normal subjects and in patients with melanoma.
Graef V; Paul E
Br J Dermatol; 1982 Jan; 106(1):53-7. PubMed ID: 6800394
[TBL] [Abstract][Full Text] [Related]
15. [5-S-cysteinyldopa in the urine - a "tumor test" for malignant melanoma? Comparison with the usual laboratory examinations].
Paul E; Graef V; Ruppel R
Z Hautkr; 1980 Dec; 55(23):1543-60. PubMed ID: 6782780
[TBL] [Abstract][Full Text] [Related]
16. [Comparative studies between excretion of 5-S-cysteinyldopa and indole melanogens in urine].
Beyer C; Fiedler H; Wohlrab W; Wozniak KD
Dermatol Monatsschr; 1986; 172(9):541-4. PubMed ID: 3098590
[No Abstract] [Full Text] [Related]
17. [Treatment of malignant melanoma with DTIC--therapeutic effects determined by 5-S-cysteinyldopa changes in the urine (proceedings)].
Agrup G; Hafström L; Jönsson PE; Rorsman H
Lakartidningen; 1978 Dec; 75(49):4599-600. PubMed ID: 364213
[No Abstract] [Full Text] [Related]
18. Photochemistry of melanin precursors: dopa, 5-S-cysteinyldopa and 2,5-S,S'-dicysteinyldopa.
Land EJ; Thompson A; Truscott TG; Subbarao KV; Chedekel MR
Photochem Photobiol; 1986 Dec; 44(6):697-702. PubMed ID: 3104937
[No Abstract] [Full Text] [Related]
19. Urinary excretion of melanocytic metabolites in fertile women.
Carstam R; Hansson C; Rorsman H; Rosengren E; Sjöberg NO; Wirestrand LE
Acta Derm Venereol; 1985; 65(6):543-5. PubMed ID: 2420122
[TBL] [Abstract][Full Text] [Related]
20. Determination of 5-S-cysteinyldopa in human urine by direct injection in coupled-column high-performance liquid chromatography.
Hansson C; Kågedal B; Källberg M
J Chromatogr; 1987 Sep; 420(1):146-51. PubMed ID: 3117824
[No Abstract] [Full Text] [Related]
[Next] [New Search]
